{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:19:53Z","timestamp":1791235193216,"version":"4.1.0"},"reference-count":22,"publisher":"Japanese Society of Hypertension","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1291\/hypres.31.229","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T01:52:06Z","timestamp":1206064326000},"page":"229-233","source":"Crossref","is-referenced-by-count":57,"title":["Adiponectin Levels Associated with the Development of Hypertension: A Prospective Study"],"prefix":"10.1291","volume":"31","author":[{"given":"Takuya","family":"IMATOH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"MIYAZAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"MOMOSE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"TANIHARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"UNE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01426.x"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0255"},{"key":"3","unstructured":"3. Tajtakova M, Petrasova D, Petrovicova J, <i>et al<\/i>: Adiponectin as a biomarker of clinical manifestation of metabolic syndrome. <i>Endocr Regul<\/i> 2006; <b>40<\/b>: 15-19."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hara K, Horikoshi M, Yamauchi T, <i>et al<\/i>: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. <i>Diabetes Care<\/i> 2006; <b>29<\/b>: 1357-1362.","DOI":"10.2337\/dc05-1801"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2003.08.004"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000048856.22331.50"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cesari M, Pessina AC, Zanchetta M, <i>et al<\/i>: Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high-risk nondiabetic patients. <i>J Intern Med<\/i> 2006; <b>260<\/b>: 474-483.","DOI":"10.1111\/j.1365-2796.2006.01714.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Im JA, Kim SH, Lee JW, <i>et al<\/i>: Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. <i>Metabolism<\/i> 2006; <b>55<\/b>: 1546-1550.","DOI":"10.1016\/j.metabol.2006.06.027"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Patel JV, Lim HS, Hughes EA, <i>et al<\/i>: Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk? <i>J Hum Hypertens<\/i> 2006; <b>21<\/b>: 1-4.","DOI":"10.1038\/sj.jhh.1002078"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dogru T, Sonmez A, Tasci I, <i>et al<\/i>: Plasma adiponectin and insulin resistance in new onset hypertension. <i>Endocrine<\/i> 2006; <b>29<\/b>: 405-408.","DOI":"10.1385\/ENDO:29:3:405"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.08.029"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000169444.05588.4c"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hong SJ, Park CG, Seo HS, <i>et al<\/i>: Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. <i>Blood Press<\/i> 2004; <b>13<\/b>: 236-242.","DOI":"10.1080\/08037050410021397"},{"key":"14","unstructured":"14. Lee HS, Lee M, Joung H: Adiponectin represents an independent risk factor for hypertension in middle aged Korean women. <i>Asia Pac J Clin Nutr<\/i> 2007; <b>16<\/b>: 10-15."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Chow WS, Cheung BM, Tso AW, <i>et al<\/i>: Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. <i>Hypertension<\/i> 2007; <b>49<\/b>: 1455-1461.","DOI":"10.1161\/HYPERTENSIONAHA.107.086835"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.705"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.45.26746"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-34785"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.6.971"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.141"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jones BH, Standridge MK, Taylor JW, <i>et al<\/i>: Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. <i>Am J Physiol<\/i> 1997; <b>273<\/b>: R236-R242.","DOI":"10.1152\/ajpregu.1997.273.1.R236"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000078490.59735.6E"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T05:46:22Z","timestamp":1557380782000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.31.229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.31.229","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}